Report Detail

Pharma & Healthcare Global (United States, European Union and China) Tysabri Market Research Report 2019-2025

  • RnM3578905
  • |
  • 08 July, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this condition.
In 2019, the market size of Tysabri is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tysabri.

This report studies the global market size of Tysabri, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tysabri sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Biogen
...

Market Segment by Product Type
Multiple Sclerosis
Crohn's Disease

Market Segment by Application
Hospital
Drugs Stores

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Tysabri status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Tysabri manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Tysabri are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Tysabri Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Multiple Sclerosis
      • 1.3.3 Crohn's Disease
    • 1.4 Market Segment by Application
      • 1.4.1 Global Tysabri Market Share by Application (2019-2025)
      • 1.4.2 Hospital
      • 1.4.3 Drugs Stores
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Tysabri Market Size
      • 2.1.1 Global Tysabri Revenue 2014-2025
      • 2.1.2 Global Tysabri Sales 2014-2025
    • 2.2 Tysabri Growth Rate by Regions
      • 2.2.1 Global Tysabri Sales by Regions 2014-2019
      • 2.2.2 Global Tysabri Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Tysabri Sales by Manufacturers
      • 3.1.1 Tysabri Sales by Manufacturers 2014-2019
      • 3.1.2 Tysabri Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Tysabri Revenue by Manufacturers (2014-2019)
      • 3.2.2 Tysabri Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Tysabri Market Concentration Ratio (CR5 and HHI)
    • 3.3 Tysabri Price by Manufacturers
    • 3.4 Key Manufacturers Tysabri Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Tysabri Market
    • 3.6 Key Manufacturers Tysabri Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Multiple Sclerosis Sales and Revenue (2014-2019)
      • 4.1.2 Crohn's Disease Sales and Revenue (2014-2019)
    • 4.2 Global Tysabri Sales Market Share by Type
    • 4.3 Global Tysabri Revenue Market Share by Type
    • 4.4 Tysabri Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Tysabri Sales by Application

    6 United States

    • 6.1 United States Tysabri Breakdown Data by Company
    • 6.2 United States Tysabri Breakdown Data by Type
    • 6.3 United States Tysabri Breakdown Data by Application

    7 European Union

    • 7.1 European Union Tysabri Breakdown Data by Company
    • 7.2 European Union Tysabri Breakdown Data by Type
    • 7.3 European Union Tysabri Breakdown Data by Application

    8 China

    • 8.1 China Tysabri Breakdown Data by Company
    • 8.2 China Tysabri Breakdown Data by Type
    • 8.3 China Tysabri Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Tysabri Breakdown Data by Company
    • 9.2 Rest of World Tysabri Breakdown Data by Type
    • 9.3 Rest of World Tysabri Breakdown Data by Application
    • 9.4 Rest of World Tysabri Breakdown Data by Countries
      • 9.4.1 Rest of World Tysabri Sales by Countries
      • 9.4.2 Rest of World Tysabri Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Biogen
      • 10.1.1 Biogen Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Tysabri
      • 10.1.4 Tysabri Product Introduction
      • 10.1.5 Biogen Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Tysabri Sales Channels
      • 11.2.2 Tysabri Distributors
    • 11.3 Tysabri Customers

    12 Market Forecast

    • 12.1 Global Tysabri Sales and Revenue Forecast 2019-2025
    • 12.2 Global Tysabri Sales Forecast by Type
    • 12.3 Global Tysabri Sales Forecast by Application
    • 12.4 Tysabri Forecast by Regions
      • 12.4.1 Global Tysabri Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Tysabri Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Tysabri. Industry analysis & Market Report on Tysabri is a syndicated market report, published as Global (United States, European Union and China) Tysabri Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Tysabri market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,587.92
      3,881.88
      5,175.84
      3,017.60
      4,526.40
      6,035.20
      508,957.60
      763,436.40
      1,017,915.20
      273,880.00
      410,820.00
      547,760.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report